Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483499 | 1.00 | DGKA (0.55) | DGKAFAAHALDH1A1CNR1CNR2 | |
| SCHEMBL5482407 | 1.00 | DGKA (0.55) | DGKAFAAHALDH1A1CNR1CNR2 | |
| SCHEMBL1768207 | 1.00 | DGKA (0.55) | DGKAFAAHALDH1A1CNR1CNR2 | |
| SCHEMBL18662301 | 0.95 | ALDH1A1 (0.57) | DGKAFAAHALDH1A1CNR1CNR2 | |
| Phosphoric Acid SCHEMBL4261864 | 0.94 | LPAR1 (0.51) | DGKAFAAH | |
| SCHEMBL23121501 | 0.90 | NAAA (0.59) | NAAA | |
| SCHEMBL118318 | 0.90 | NAAA (0.59) | NAAA | |
| SCHEMBL114472 | 0.90 | NAAA (0.59) | NAAA | |
| SCHEMBL117824 | 0.90 | NAAA (0.59) | NAAA | |
| SCHEMBL23467113 | 0.90 | NAAA (0.59) | NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2741 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210106538-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2021-04-15 | — | — | US | claimed |
| EP-3471778-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | The Regents of The University of Michigan (US) | 2019-04-24 | — | — | EP | claimed |
| WO-2017223085-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-12-28 | — | — | WO | claimed |
| US-20150337018-A1 | USE OF COMPOUNDS THAT SELECTIVELY MODULATE ASTROCYTIC RELEASE OF SUBSTANCES THROUGH HEMICHANNELS OF CONNEXINS AND PANNEXINS, WITHOUT INFLUENCING GAP JUNCTIONS, FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | UNIVERSIDAD ANDRES BELLO (CL) | 2015-11-26 | — | — | US | claimed |
| EP-2897632-A2 | COMPOUNDS MODULATING ASTROCYTIC RELEASE OF SUBSTANCES THROUGH CONNEXINS AND PANNEXINS AND TREATMENT OF PSYCHIATRIC DISORDERS | Universidad Andres Bello (CL) | 2015-07-29 | — | — | EP | claimed |
| WO-2013179264-A2 | USE OF COMPOUNDS THAT SELECTIVELY MODULATE ASTROCYTIC RELEASE OF SUBSTANCES THROUGH HEMICHANNELS OF CONNEXINS AND PANNEXINS, WITHOUT INFLUENCING GAP JUNCTIONS, FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | UNIVERSIDAD ANDRES BELLO (CL) | 2013-12-05 | — | — | WO | claimed |
| US-20040154921-A1 | Method for electrophoretic sample separation | XZILLION GMBH & CO. KG (DE) | 2004-08-12 | — | — | US | claimed |
| EP-1399734-A2 | METHOD FOR ELECTROPHORETIC SAMPLE SEPARATION | Xzillion Proteomics GmbH & CO.KG (DE) | 2004-03-24 | — | — | EP | claimed |
| US-20030204077-A1 | RNA isolation reagent and methods | INVITROGEN CORPORATION | 2003-10-30 | — | — | US | claimed |
| EP-1005479-A4 | RNA ISOLATION REAGENT AND METHODS | LIFE TECHNOLOGIES INC (US) | 2002-12-18 | — | — | EP | claimed |
| WO-2002099404-A2 | METHOD FOR ELECTROPHORETIC SAMPLE SEPARATION | XZILLION PROTEOMICS GMBH & CO. KG (DE) | 2002-12-12 | — | — | WO | claimed |
| EP-1005479-A1 | RNA ISOLATION REAGENT AND METHODS | LIFE TECHNOLOGIES, INC. (US) | 2000-06-07 | — | — | EP | claimed |
| WO-1998045311-A1 | RNA ISOLATION REAGENT AND METHODS | LIFE TECHNOLOGIES, INC. (US) | 1998-10-15 | — | — | WO | claimed |
| US-20260146252-A1 | COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS | IONIS PHARMACEUTICALS, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4744669-A2 | APOLIPOPROTEIN C3 (APOC3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF | Alnylam Pharmaceuticals, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| WO-2026101913-A1 | SIRNAS TARGETING COMPLEMENT FACTOR H-RELATED (CFHR) GENE TRANSCRIPTS AND METHODS OF USE | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-1999001579-A1 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF OLIGONUCLEOTIDES VIA THE ALIMENTARY CANAL | ISIS PHARMACEUTICALS, INC. (US) | 1999-01-14 | — | — | WO | disclosed |
| EP-0287652-A4 | SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS. | LIFE TECHNOLOGIES INC (US) | 1990-01-08 | — | — | EP | disclosed |
| EP-0287652-A1 | SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS. | LIFE TECHNOLOGIES INC (US) | 1988-10-26 | — | — | EP | disclosed |
| WO-1988002774-A1 | SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS | LIFE TECHNOLOGIES, INC. (US) | 1988-04-21 | — | — | WO | disclosed |